期刊文献+

2010年欧洲呼吸学会和欧洲胸外科学会恶性胸膜间皮瘤诊疗指南简介 被引量:1

原文传递
导出
摘要 恶性胸膜间皮瘤是一种罕见疾病,且为一种预后很差的肿瘤,但其发病率逐年上升。欧洲呼吸学会和欧洲胸外科学会特别工作组于2010年正式颁布了欧洲呼吸学会和欧洲胸外科学会恶性胸膜间皮瘤诊疗指南。今将指南简介如下。读者如要仔细研究指南,请参阅欧洲呼吸杂志刊登的全文。
作者 张力 蔡柏蔷
出处 《国际呼吸杂志》 2010年第10期577-580,共4页 International Journal of Respiration
  • 相关文献

参考文献1

二级参考文献100

  • 1Bottomley A, Coens C, Efficace F, et al. Symptoms and patientreported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTCNCIC08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.J Clin Oncol,2007; 25: 5770-5776.
  • 2Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion.Chest 1995; 107: 1454-1456.
  • 3Soysal O, Karaoglanoglu N, Demiracan S, et al. Pleurectomy/ decortication for palliation in malignant pleural mesothelioma:results of surgery. EurJ Cardiothorac Surg 1997; 11: 210-213.
  • 4Halstead JC, Lim E, Venkateswaran RM, et al. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 2005; 31: 314-320.
  • 5Nakas A, Martin Ucar AE, Edwards JG, et al. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 33: 83-88.
  • 6Martin-Ucar AE, Edwards JG, Rengajaran A, et al. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. EurJ Cardiothorac Surg 2001; 20:1117-1121.
  • 7Dogan AUp Baris YI, Dogan M, et al. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 2006; 66: 5063-5068.
  • 8Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet 2007; 369: 844-849.
  • 9Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-1603.
  • 10Segura O, Burdorf A, Looman C, Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003; 60: 50-55.

共引文献56

同被引文献17

  • 1Zucali PA, De Vincenzo F, Simonelli M, et al. Future develop- ments in the management of malignant pleural mesothelioma [ J ]. Expert Rev Anticancer Ther, 2009,9(4) :453-467.
  • 2Chen SE, Pace MB. Malignant pleural mesothelioma [ J ]. Am J Health Syst Pharm, 2012,69 (5) :377-385.
  • 3Oken MM, Creech RH, Tormey DC, et al. Toxicity and Response Criteria of the Eastern Cooperative Oncology Group[ J]. Am J Clin Oncol, 1982,5:649-655.
  • 4Kent M, Rice D, Flores R. Diagnosis, staging, and surgical treat- ment of malignant pleural mesothelioma[J]. Curr Treat Options On- col,2008,9 ( 2-3 ) : 158-170.
  • 5Robinson BW, Lake RA. Advances in malignant mesothelioma[ J]. N Engl J Med, 2005,353:1591-1603.
  • 6Campbell NP, Kindler HL. Update on Malignant Pleural Mesothelio- ma[J]. Semin Respir Crit Care Med,2011,32( 1 ) :102-110.
  • 7Robinson BW, Musk AW, Lake RA. Malignant mesothelioma[J]. Lancet, 2005,366:397-408.
  • 8Otsuka H, Terazawa K, Morita N, et al. Is FDG-PET/CT useful for managing malignant pleural mesothelioma [ J ]. J Med Invest, 2009, 56(1-2) :16-20.
  • 9Yildirim H, Metintas M, Entok E, et al. Clinical value of fluorode- oxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related be- nign pleural disease: an observationl pilot study [ J ]. J Thorac On- col, 2009,4(12) :1480-1484.
  • 10Husain AN,Colby TV, Ordonez NG, et al. Guidelines for patholog- ic diagnosis of malignant: a consensus statement from the Interna- tional Mesothelioma Interest Group [ J ]. Arch Pathol Lab Med, 2009,133(8) :1317-1331.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部